We are analyzing https://link.springer.com/article/10.1007/bf00665783.

Title:
MCF-7 breast cancer cells overexpressing transfectedc-erbB-2 have anin vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivityin vivo | Breast Cancer Research and Treatment
Description:
Ac-erbB-2 expression vector was transfected into the estrogen receptor positive (ER+) MCF-7 human breast cancer cell line to determine if overexpression of this transmembrane tyrosine kinase could increase the malignant phenotype of this cell line. Loss of transfectedc-erbB-2 expression was observed when cells were carried in medium containing estrogen. Homogeneous populations stably overexpressing levels of the 185 kDac-erbB-2 observed in the SKBR-3 a breast cancer cell line which overexpressesc-erbB-2 as a result of gene amplification could be obtained by continually maintaining the transfected cell lines in estrogen-free conditions. Levels of constitutively activatedc-erbB-2 varied among clonal isolates. Whereas some over-expressing lines did acquire the ability to form transient tumor nodules in ovariectomized nude mice without estrogen supplementation, as well as in mice that received the antiestrogen tamoxifen, one cell line that exhibited the highest levels of constitutively activatedc-erbB-2 was able to form static tumors of a larger size under both conditions. This same cell line formed progressively growing tumors in estrogen-supplemented mice that were much larger than observed in mice injected with control cell lines, and also showed reduced sensitivity to antiestrogensin vitro, but it continued to have a low metastatic phenotype. These results suggest that signal transduction mediated by thec-erbB-2 tyrosine kinase can partially overcome the estrogen dependence of ER+ breast cancer cells for growth and thatc-erbB-2 overexpression confers a selective advantage to such cells in the absence of estrogen.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

google, scholar, cancer, breast, growth, cells, cell, human, oncogene, receptor, factor, expression, cerbb, tyrosine, mcf, usa, res, epidermal, overexpression, natl, protein, herneu, protooncogene, dickson, lippman, article, estrogen, kinase, mice, proc, acad, sci, egf, erbb, mammary, overexpressing, kern, line, gene, lines, neu, ullrich, king, biol, epithelial, receptors, carcinoma, research, vitro, conditions,

Topics {✒️}

activated c-ha-ras protooncogene activated c-erbb-2 gene erbb-2/neu proto-oncogene product month download article/chapter mcf-7 cells overexpressing estrogen-dependent mcf-7 cells anti-p185her2 monoclonal antibody regulates c-erbb-2 expression constitutively activatedc-erbb-2 varied c-erbb-2 proto-oncogene thec-erbb-2 tyrosine kinase theerb-b3 tyrosine kinase ligand-independent tyrosine phosphorylation thatc-erbb-2 overexpression confers egf-stimulated tyrosine phosphorylation tamoxifen-resistant tumorigenic growth cell-type specific interaction c-erbb-2 protein overexpression c-erbb-2 oncogene expression epidermal growth factor transfectedc-erbb-2 expression mcf-7 cells transfected egf-dependent transformed phenotype serum-free cell culture block ligand-dependent transformation oncogenes c-myc human breast carcinoma mammary tumor cells human carcinoma cells tamoxifen-sensitivityin vivo breast cancer growth human breast cancer c-ha-ras alpha 2-integrin subunit ductal carcinomain situ transfected cell lines privacy choices/manage cookies constitutively activatedc-erbb-2 breast cancer [editorial] invasive breast cancer advanced breast cancer cell growth differ truncated receptor form 2 proto-oncogene product multiple independent activations antigen immunologically related c-neu protooncogene erbb-2 oncogene product normal erbb-2 product control cell lines

Schema {🗺️}

WebPage:
      mainEntity:
         headline:MCF-7 breast cancer cells overexpressing transfectedc-erbB-2 have anin vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivityin vivo
         description:Ac-erbB-2 expression vector was transfected into the estrogen receptor positive (ER+) MCF-7 human breast cancer cell line to determine if overexpression of this transmembrane tyrosine kinase could increase the malignant phenotype of this cell line. Loss of transfectedc-erbB-2 expression was observed when cells were carried in medium containing estrogen. Homogeneous populations stably overexpressing levels of the 185 kDac-erbB-2 observed in the SKBR-3 a breast cancer cell line which overexpressesc-erbB-2 as a result of gene amplification could be obtained by continually maintaining the transfected cell lines in estrogen-free conditions. Levels of constitutively activatedc-erbB-2 varied among clonal isolates. Whereas some over-expressing lines did acquire the ability to form transient tumor nodules in ovariectomized nude mice without estrogen supplementation, as well as in mice that received the antiestrogen tamoxifen, one cell line that exhibited the highest levels of constitutively activatedc-erbB-2 was able to form static tumors of a larger size under both conditions. This same cell line formed progressively growing tumors in estrogen-supplemented mice that were much larger than observed in mice injected with control cell lines, and also showed reduced sensitivity to antiestrogensin vitro, but it continued to have a low metastatic phenotype. These results suggest that signal transduction mediated by thec-erbB-2 tyrosine kinase can partially overcome the estrogen dependence of ER+ breast cancer cells for growth and thatc-erbB-2 overexpression confers a selective advantage to such cells in the absence of estrogen.
         datePublished:
         dateModified:
         pageStart:97
         pageEnd:117
         sameAs:https://doi.org/10.1007/BF00665783
         keywords:
            breast cancer
             c-erbB-2
            HER-2/neu
            growth factors
            growth factor receptors
            transfection
            Oncology
         image:
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:34
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Kluwer Academic Publishers
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Yiliang Liu
               affiliation:
                     name:Georgetown University Medical Center
                     address:
                        name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Dorraya El-Ashry
               affiliation:
                     name:Georgetown University Medical Center
                     address:
                        name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
                        type:PostalAddress
                     type:Organization
                     name:Georgetown University Medical Center
                     address:
                        name:Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, DC, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Denise Chen
               affiliation:
                     name:Georgetown University Medical Center
                     address:
                        name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ivan Yi Fan Ding
               affiliation:
                     name:Georgetown University Medical Center
                     address:
                        name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Francis G. Kern
               affiliation:
                     name:Georgetown University Medical Center
                     address:
                        name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
                        type:PostalAddress
                     type:Organization
                     name:Georgetown University Medical Center
                     address:
                        name:Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, DC, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:MCF-7 breast cancer cells overexpressing transfectedc-erbB-2 have anin vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivityin vivo
      description:Ac-erbB-2 expression vector was transfected into the estrogen receptor positive (ER+) MCF-7 human breast cancer cell line to determine if overexpression of this transmembrane tyrosine kinase could increase the malignant phenotype of this cell line. Loss of transfectedc-erbB-2 expression was observed when cells were carried in medium containing estrogen. Homogeneous populations stably overexpressing levels of the 185 kDac-erbB-2 observed in the SKBR-3 a breast cancer cell line which overexpressesc-erbB-2 as a result of gene amplification could be obtained by continually maintaining the transfected cell lines in estrogen-free conditions. Levels of constitutively activatedc-erbB-2 varied among clonal isolates. Whereas some over-expressing lines did acquire the ability to form transient tumor nodules in ovariectomized nude mice without estrogen supplementation, as well as in mice that received the antiestrogen tamoxifen, one cell line that exhibited the highest levels of constitutively activatedc-erbB-2 was able to form static tumors of a larger size under both conditions. This same cell line formed progressively growing tumors in estrogen-supplemented mice that were much larger than observed in mice injected with control cell lines, and also showed reduced sensitivity to antiestrogensin vitro, but it continued to have a low metastatic phenotype. These results suggest that signal transduction mediated by thec-erbB-2 tyrosine kinase can partially overcome the estrogen dependence of ER+ breast cancer cells for growth and thatc-erbB-2 overexpression confers a selective advantage to such cells in the absence of estrogen.
      datePublished:
      dateModified:
      pageStart:97
      pageEnd:117
      sameAs:https://doi.org/10.1007/BF00665783
      keywords:
         breast cancer
          c-erbB-2
         HER-2/neu
         growth factors
         growth factor receptors
         transfection
         Oncology
      image:
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:34
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Kluwer Academic Publishers
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Yiliang Liu
            affiliation:
                  name:Georgetown University Medical Center
                  address:
                     name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Dorraya El-Ashry
            affiliation:
                  name:Georgetown University Medical Center
                  address:
                     name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
                     type:PostalAddress
                  type:Organization
                  name:Georgetown University Medical Center
                  address:
                     name:Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, DC, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Denise Chen
            affiliation:
                  name:Georgetown University Medical Center
                  address:
                     name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ivan Yi Fan Ding
            affiliation:
                  name:Georgetown University Medical Center
                  address:
                     name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Francis G. Kern
            affiliation:
                  name:Georgetown University Medical Center
                  address:
                     name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
                     type:PostalAddress
                  type:Organization
                  name:Georgetown University Medical Center
                  address:
                     name:Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, DC, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:34
Organization:
      name:Kluwer Academic Publishers
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Georgetown University Medical Center
      address:
         name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
         type:PostalAddress
      name:Georgetown University Medical Center
      address:
         name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
         type:PostalAddress
      name:Georgetown University Medical Center
      address:
         name:Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, DC, USA
         type:PostalAddress
      name:Georgetown University Medical Center
      address:
         name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
         type:PostalAddress
      name:Georgetown University Medical Center
      address:
         name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
         type:PostalAddress
      name:Georgetown University Medical Center
      address:
         name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
         type:PostalAddress
      name:Georgetown University Medical Center
      address:
         name:Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, DC, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Yiliang Liu
      affiliation:
            name:Georgetown University Medical Center
            address:
               name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
               type:PostalAddress
            type:Organization
      name:Dorraya El-Ashry
      affiliation:
            name:Georgetown University Medical Center
            address:
               name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
               type:PostalAddress
            type:Organization
            name:Georgetown University Medical Center
            address:
               name:Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, DC, USA
               type:PostalAddress
            type:Organization
      name:Denise Chen
      affiliation:
            name:Georgetown University Medical Center
            address:
               name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
               type:PostalAddress
            type:Organization
      name:Ivan Yi Fan Ding
      affiliation:
            name:Georgetown University Medical Center
            address:
               name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
               type:PostalAddress
            type:Organization
      name:Francis G. Kern
      affiliation:
            name:Georgetown University Medical Center
            address:
               name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
               type:PostalAddress
            type:Organization
            name:Georgetown University Medical Center
            address:
               name:Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, DC, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
      name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
      name:Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, DC, USA
      name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
      name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
      name:Lombardi Cancer Research Center, Room S107, Georgetown University Medical Center, Washington, DC, USA
      name:Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, DC, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(105)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.42s.

LINK . SPRINGER . COM {}